Leadership transition and why it matters for CorVel stock

CorVel (CRVL) has set July 1, 2026 as the date for a major leadership transition, with long-time executive Sarah Scott taking over as CEO and President and Michael G. Combs moving to Executive Chair.

The leadership news comes after a mixed run for investors, with a 90 day share price return of 18.76% and a 1 year total shareholder return that declined 43.41%. This suggests weaker long term momentum alongside a recent improvement.

If this leadership change has you reviewing your watchlist, it could be a good moment to broaden your search and check out the 19 top founder-led companies

With CorVel stock down over 43% on a 1 year view but showing an intrinsic discount of about 37%, the key question is whether this reflects a mispriced opportunity or if the market is already factoring in future growth.

Preferred P/E of 28.1x: Is it justified?

CorVel last closed at $61.15, and on a P/E of 28.1x it is priced higher than the broader US Healthcare industry average of 23x, while still below the peer group average of 82.6x.

The P/E ratio compares the share price to earnings per share, so a higher multiple often reflects the market placing a richer value on each dollar of current earnings. For CorVel, that higher multiple sits alongside earnings growth of 14.5% per year over the past 5 years, a 16% earnings result in the most recent year, and a return on equity of 28%.

Against the industry, CorVel looks expensive, as its 28.1x P/E stands well above the 23x Healthcare industry average. However, when lined up against its specific peer set, the same 28.1x looks restrained, because the peer average sits at a very high 82.6x, which is a level the market could move away from if expectations reset.

Result: Price-to-earnings of 28.1x (ABOUT RIGHT)

However, the story can still change quickly if higher expectations around CorVel's P/E meet weaker earnings or if its US focused revenue base comes under pressure.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another view on CorVel's value

The earnings based P/E picture is only one angle. Our DCF model points to a fair value of about $97.39 per share, compared with the current $61.15 price, which implies CorVel trades at a sizeable discount. Is this a margin of safety or a sign the market sees risks that the model cannot?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out CorVel for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 47 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With mixed signals from the share price, valuation and leadership changes, it makes sense to look at the underlying data yourself and decide quickly how it all fits together for your portfolio. To round out the picture, review the 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If CorVel has your attention, do not stop here. Use this momentum to scan wider opportunities so you are not leaving potential ideas on the table.

• Target stable growth by reviewing companies in the 47 high quality undervalued stocks that combine fair pricing with appealing fundamentals.
• Prioritize resilience and sleep better at night by checking stocks in the 63 resilient stocks with low risk scores with calmer risk profiles.
• Zero in on financial strength by focusing on companies listed in the solid balance sheet and fundamentals stocks screener (46 results) that put balance sheet quality front and center.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.